Dr Ambrish Mithal writes for Firstpost on microdosing GLP-1 drugs
The endocrinologist takes on the growing habit of taking GLP-1 drugs in small doses, in a piece written for Firstpost.
Recap by typeshit. Post by Dr Ambrish Mithal on X.
The endocrinologist takes on the growing habit of taking GLP-1 drugs in small doses, in a piece written for Firstpost.
Recap by typeshit. Post by Dr Ambrish Mithal on X.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
A general drug reference post pointing to tirzepatide basics like interactions and warnings. Evergreen material with no new development behind it.
She says kids who meet certain criteria can get GLP-1 agonists, usually through a paediatric endocrinologist, since it's a specialised medication.
Loading…